3/21
07:41 am
cgtx
Rating for CGTX
Medium
Report
Rating for CGTX
2/26
06:18 pm
cgtx
Cognition Therapeutics, Inc. (NASDAQ: CGTX) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $11.00 price target on the stock.
Low
Report
Cognition Therapeutics, Inc. (NASDAQ: CGTX) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $11.00 price target on the stock.
2/26
06:04 pm
cgtx
Rating for CGTX
Low
Report
Rating for CGTX